<DOC>
	<DOCNO>NCT00449111</DOCNO>
	<brief_summary>Evaluate blood pressure 6 week treatment COZAAR plus .</brief_summary>
	<brief_title>An Open Label Study Assess Efficacy , Safety Tolerability COZAAR Plus ( Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg ) Possibly Titrated COZAAR Plus-F ( Losartan Potassium 100mg/Hydrochlorothiazide 25mg ) Patients With Essential Hypertension ( 0954A-325 )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Patient treat valsartan 80mg irbesartan 150mg vandesartan 8mg least 4 week prior visit 1 Patient systolic blood pressure 140 159 mmhg diastolic pressure 90 99mmhg take visit 1 History angina pectoris stabilize past 6 week History clinically significant abnormal lab result diseases Myocardial infarction within past 6 month Stroke past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>